Healthier Population Eases Australia’s Disease Burden

Facts and figures:

The Good

  • Reductions in premature deaths from illnesses and injuries such as cardiovascular diseases, cancer, and infant and congenital conditions.
  • For the first time, living with illness or injury caused more total disease burden than premature death.
  • In 2015, the non-fatal share was 50.4% and the fatal share was 49.6% of the burden of disease.

The Bad

  • Australian’s lost 4.8 million years of healthy life due to living with or dying prematurely from disease and injury
  • Diseases of most burden, were cancer, cardiovascular diseases, musculoskeletal conditions, mental and substance use disorders and injuries.
  • The 5 risk factors that caused the most total burden in 2015 were tobacco use (9.3%), overweight & obesity (8.4%), dietary risks (7.3%), high blood pressure (5.8%) and high blood plasma glucose—including diabetes (4.7%).
  • 38% of the total burden of disease could have been prevented by reducing exposure to these five risk factors.

The details:

The full report can be found at www.aihw.gov.au/reports/burden-of-disease/australian-burden-disease-study-methods-2015/contents/table-of-contents

Leading Melbourne Hospital Follows in Digital Records Trend

What does it mean:

For patients

A mobile and website application will give patients access to their own information and from any location. Through the portal, patients will be able to see and manage any upcoming appointments, test results, and medications that have been prescribed.

For general practitioners

With consent, will be able to access and amended patient information from anywhere,

The details

The Royal Melbourne’s Emergency Department will be the first to move to the new EMR on 30 June this year. All other areas at RMH, Peter Mac and the Women’s will start using the new EMR on 2 May 2020.

Further details on the company Epic can be found at www.epic.com

Breakthrough Link For Parkinson and MND Sufferers

[vc_row][vc_column][vc_column_text]

Facts and figures:

Researchers chose 19 patients for the trial, who were assigned to three different dose cohorts throughout six, 28-day cycle periods. Those in the highest dose group, who took 72mg of CuATSM per day, reported vast improvements in quality of life and symptom severity.

A recent trial of 32 motor neurone disease patients also found CuATSM slowed the progression of the disease and improved cognitive and motor ability.

Ask the expert:

Neurologist Dr Andrew Evans from the Royal Melbourne Hospital:

“The impact has been that (patients) feel better, but also it gives them hope for the future that they are not going to decline in the same way that most patients will do.”

The details:

For more information about clinical trials at The Royal Melbourne Hospital visit www.thermh.org.au/research/clinical-trials

[/vc_column_text][/vc_column][/vc_row]

New Digital Storytelling Platform For Youth Mental Health

[vc_row][vc_column][vc_column_text]Facts and figures:

$2.8 million in funding will be given to the batyr program aiming to further enhance and expand their online presence to support youth mental health and suicide, through safe and effective digital storytelling in schools.

It is estimated one in four young Australians aged 16 to 24 experience mental illness in any given year.

The funding forms part of the $5.3 billion national mental health and suicide prevention plan.

Ask the expert:

Prime Minister Scott Morrison

“This is a program for young people, designed by young people.”

“This will help batyr deliver front-line services and coordinate the right interventions for at-risk young people.”

“Their approach is part of our vision for tackling the mental health challenges facing young Australians and that is a key focus of my government.”

The details:

More information about batyr can be found at www.batyr.com.au/about-us[/vc_column_text][/vc_column][/vc_row]

Trial Finds New Drug Can Delay Type 1 Diabetes

Facts and figures:

The study published in the New England Journal of Medicine ran for five years and involved 76 children and young adults at very high risk of developing type 1 diabetes.

‘Teplizumab’ delayed the onset of diabetes by two years.

The Royal Melbourne Hospital is one of 28 sites that participated in the study conducted by TrialNet, the largest clinical trial network ever assembled to discover ways to delay and prevent type 1 diabetes.

This trial is being run in conjunction with several others that will likely have major changes for diabetes worldwide.

Ask the expert:

The Royal Melbourne Hospital’s Associate Professor John Wentworth

“We have known for over 3 decades how to identify children who are destined to develop type 1 diabetes. Now, for the first time, we have something that will improve their prospects and delay the need to start insulin injections to control blood sugar levels.”

“These results are incredibly encouraging.”

The details:

For more information about current Australian clinical trials can be found at www.diabetesresearchcentre.org.au/clinical-trials

More information about TrialNet can be found at www.trialnet.org

Seven Pharmacists Recognised in 2019 Queen’s Birthday Awards

[vc_row][vc_column][vc_column_text]

The list:

From New South Wales:

  • Mr Warwick Plunkett
  • Mrs Carlene Smith
  • Ms Juliet Seifert
  • Mr David North
  • Mrs Dianne North

From Queensland:

  • Emeritus Professor Maree Therese Smith
  • Ms Catherine Reid

Ask the expert:

PSA National President Dr Chris Freeman

“I sincerely congratulate all of today’s Queen’s Birthday Honours recipients and thank them for their ongoing service to the pharmacy profession and their local communities,”

The details:

Further details of achievements and a full list of the Queen’s Birthday Honours is available on the Governor-General’s website.

https://www.gg.gov.au/queens-birthday-2019-honours-list

[/vc_column_text][/vc_column][/vc_row]

Australia’s Health System Explained

[vc_row][vc_column][vc_column_text]The World Health Organization describes a good health system as one that ‘delivers quality services to all people, when and where they need them’. In Australia, our health system is best descried as a complex mix of health professionals and service providers from a range of organisations, including government and non-government sectors, working to meet the health care needs of all Australians.

Australia’s health system has multiple components – health promotion, primary health care, specialist services and hospitals. To meet individual health care needs, a person may need – or have to engage with – the services of more than one part of the system.

1. Primary health care

Primary health care is often a person’s first contact with the health system. It comprises a range of services that are not referred: general practice, allied health services, pharmacy and community health. Various health professionals deliver these, including GPs, nurses, allied health professionals, community pharmacists, dentists and ATSI health workers.

2. Specialist services

Specialist services support people with specific or complex health conditions and issues, such as antenatal services for pregnancy, radiotherapy treatment for cancer and mental health services. Specialist services are generally referred by primary health care providers and often described as ‘secondary’ health care services.

3. Hospitals

Hospitals are a crucial part of Australia’s health system, delivering a range of services to admitted and non-admitted patients (outpatient clinics and emergency department care). All public hospitals in Australia are part of a Local Hospital Network.

State and territory governments largely own and manage public hospitals – which usually provide ‘acute care’ for short periods. Private hospitals are mainly owned and operated by either for-profit or not-for-profit organisations.

Australia’s health system may be more accurately described as various connected health systems, rather than one unified system. The Australian Government, state and territory governments and local governments share responsibility for it, including for its operation, management and funding. While the overarching framework for the health system is laid out by government, the private sector also operates and funds some health services. These including operating private hospitals, pharmacies and many medical practices, as well as funding through private health insurance.

Changes to Australia’s Constitution in 1946 allowed the Federal Government to become involved in the funding of public hospital services, resulting in the funding, operational and regulatory arrangements that exist today.

Australia’s health system is underpinned by Medicare – a universal public health insurance scheme. Medicare is funded by the Australian Government through general taxation revenue and a 2% Medicare levy. Intergovernmental arrangements for public hospital funding between the Australian Government and state and territory governments guarantee Medicare cardholders access to fee-free treatment as public patients in public hospitals. Medicare also covers a portion of the Medicare Benefits Schedule fee for medical services and procedures, and Medicare cardholders have access to a range of prescription pharmaceutical subsidies under the Pharmaceutical Benefits Scheme.

Some medical and allied health services are not subsidised through Medicare. For example, Medicare does not usually cover costs for ambulance services, most dental examinations and treatments, physiotherapy and optical aids (such as glasses and contact lenses).

Private health insurance is also an option for meeting health care expenses in Australia. People can choose the type of cover to buy. The two types of cover available are:

  • Hospital cover for some (or all) of the costs of hospital treatments as a private patient;
  • General treatment (‘ancillary’ or ‘extras’) cover for some non-medical health services not covered by Medicare – such as dental, physiotherapy and optical services.

Private health insurance works in tandem with the publicly funded system but does not cover the entirety of a private patient’s costs. Part of the cost of hospital admission as a private patient is covered by Medicare (the medical fee) and part can be covered by insurance.

The Australian Government and state and territory governments are responsible for the regulation of the health system. Various regulatory agencies within the system work to ensure that acceptable standards and quality of care and services are met, and that people are protected when using health goods and services and when dealing with health professionals.

The Australian Government is also responsible for regulating the safety and quality of pharmaceutical and therapeutic goods and appliances. The Therapeutic Goods Administration (TGA) is responsible for regulating therapeutic goods, including prescription medicines, vaccines, sunscreens, vitamins and minerals, and medical devices.

The Australian Government is also responsible for the Prostheses List. The Prostheses List is a list of medical devices that private health insurers are required to pay a benefit for when one of their members has the relevant coverage. For instance, if a member of a health fund has hospital orthopaedic cover and requires a hip replacement, their health fund is required to pay the minimum benefit for any artificial hip listed on the Prostheses List, with generally no out-of-pocket expenses for the patient.

This arrangement ensures surgeons can choose the best available medical device for their privately insured patients without private health insurers restricting their options.

The List is an essential part of the private health insurance offering, enabling Australians with private health insurance to receive the best quality heal care as determined by their doctor, and not by their health insurance provider.

While Australia’s health care system may indeed seem complex and confusing, it is still one of the best health care systems in the world.[/vc_column_text][vc_column_text]

Information in this article has been informed by the Australian Institute of Health and Welfare report, 'Australia's Health 2018'.

[/vc_column_text][/vc_column][/vc_row]

New Zealand MedTech To Be Impacted

[vc_row][vc_column][vc_column_text]The Government is introducing a new regulatory scheme for therapeutic products, and in addition, PHARMAC, the medicines purchasing agency, is extending its authority over medical devices in public (District Health Board – DHB) hospitals.

A draft bill setting out the framework for the new regulatory regime was released for consultation earlier in the year.  The purpose of the proposed Bill is to:

1. a) ensure acceptable safety, quality, and efficacy or performance of therapeutic products across their lifecycle; and

(b) regulate the manufacture, import, promotion, supply, and administration or use of therapeutic products.

Following the consultation process, a Bill is proposed for introduction into Parliament by the end of 2019 and scheduled for commencement from late 2022.

In addition to these regulatory changes, funding arrangements for devices are also changing -presenting a number of challenges to those operating in New Zealand.

PHARMAC was created in 1993 to manage government spending on medicines. Whilst there is a lot of debate around its impact on the health budget and patient access to innovative medicines, it is undeniable that it has delivered lower spending growth on pharmaceuticals.

New Zealand now has one of the lowest public spends on pharmaceuticals in the OECD. But New Zealand also ranked lowest in the OECD for the proportion of new medicines that are subsidised (2010-2015) – 12% compared with 48% for Australia, and 58% for the OECD on average.  And in 2013, generics accounted for more than three-quarters of the volume of pharmaceuticals in New Zealand.

Since 2012, PHARMAC has been working on the procurement of hospital medical devices including introducing the first national contracts for devices in 2014 and implementing the first market share procurement for wound care in 2017/18.  They now have $200 million under contract.

PHARMAC wants to commence the next phase of its work on medical devices as early as 2020. This would see PHARMAC deciding which medical devices are funded and also making decisions about introducing new technology that DHB hospitals can use.

The conflation of these two changes have significant implications for the 240 companies operating in the medical devices sector in New Zealand. The PHARMAC approach will potentially erode patient and clinician choice, training and education for medical professionals, long term competition and viability of the sector, timely access to innovative therapies, value in healthcare and overall patient outcomes.

The PHARMAC proposal is open for consultation until 28 June 2019.[/vc_column_text][/vc_column][/vc_row]

Labor’s New Shadow Minister for Health Chris Bowen

[vc_row][vc_column][vc_column_text]Christopher Eyles Guy Bowen was born in Sydney and educated at Smithfield Public School and St Johns Park High School in New South Wales. Bowen attended the University of Sydney where he graduated with a Bachelor of Economics, later completing a Masters of International Relations from Griffith University and a Diploma in Modern Languages (Bahasa Indonesia) from the University of New England.

At the age of 22, Bowen worked as a research and media officer to the then Member for Prospect, Janice Crosio MBE, before joining the Finance Sector Union as an industrial from 1995-2000. In 2001 Bowen took up an offer to join the staff of NSW Minister for Roads, Housing and Leader of the House, Patrick Carl Scully as first a Senior Advisor and later as Chief of Staff.

Bowen first started his career in public life when he was elected to Fairfield Council in 1995, and subsequently as mayor from 1998-1999. Between 1999-2001, Bowen went on to become the President of the Western Sydney Regional Organisation of Councils.

In 2004, Bowen stood and was elected for the Federal seat of McMahon to replace his former boss, Janice Crosio, who retired after 25 years in politics.

In 2006, Bowen was appointed to Labor’s frontbench by then Opposition Leader, Kevin Rudd, as Shadow Assistant Treasurer and Shadow Minister for Revenue and Competition Policy.

During the Rudd-Gillard government, Bowen held a wide range of ministerial portfolios, including:

  • Minister for Human Services (2009-2010);
  • Minister for Immigration and Citizenship (2010-2013);
  • Minister for Tertiary Education, Skills, Science and Research (2013); and
  • Minister for Small Business (2013).

After the Labor Government’s 2013 election defeat, Bowen served as interim Labor Leader and Acting Leader of the Opposition during the Labor leadership elections. Following the election of Bill Shorten as Labor Leader and Leader of the Opposition, Bowen was appointed Shadow Treasurer – a position he was well prepared for given his many years working in treasury portfolios.

During his time as Labor’s treasury spokesman, Bowen noted his areas of policy interest included wealth creation, housing affordability and protection of Medicare and of penalty rates. He was also the Opposition’s most vocal advocate for a Royal Commission into banking.

In the lead up to the 2019 Federal Election, many believed that Bowen was Australia’s next Treasurer-in-waiting. However, this was not to be, following Prime Minister Scott Morrison historic election upset that saw the Coalition form a majority government, and reduce Labor’s numbers in the House of Representatives.

In June 2019, after Anthony Albanese was appointed Labor Leader, uncontested, Bowen was moved from the shadow treasury portfolio to the shadow health portfolio, replacing well known health advocate Catherine King.

Upon appointment Bowen released a statement outlining his biggest focuses for the portfolio area, including:

  • Tackling the scourge of diabetes, obesity and the other health challenges in areas of low income and poor health outcomes;
  • Closing the Gap of Indigenous disadvantage in health;
  • Maintaining a passionate interest in mental health and suicide prevention; and
  • Ensuring Medicare is protected and grown.

The statement also reflected that, as the longest serving Shadow Treasurer in Australian history, it was time to hand over the portfolio. Bowen also used the opportunity to acknowledge the work of Catherine King, noting her six years advocating for a better healthcare system for all Australians.

The health sector has welcomed Bowen’s appointment, citing his extensive previous experience and his ability for pragmatic and forward thinking. The Consumer Health Forum released a statement outlining that Bowen brings an impressive record to his new portfolio.

Consumer Health Forum CEO, Leanne Wells, said it was “encouraging to see that he (Bowen) has wasted no time setting out his key priorities, including countering obesity, mental illness and close the gap of indigenous health disadvantage”.

Any industry hopes of a bi-partisan approach to health may have already been dashed. Following Bowen’s appointment to the health portfolio, Minister for Health, Greg Hunt, said in a Tweet: “ Congratulations to Chris Bowen as Labor Health Spokesperson – however, he’s the man who forgot to allocate any funding for a hospital’s agreement despite pledging to do so for 6 years – big promises – zero dollars when it counted.”

The next three years will be critical for the Australian health landscape, with many in the industry wanting a clear and concise policy agenda to be set, so as to sure up investment and funding. The next three years will be one of keen interest and industry engagement for both Greg Hunt and Chris Bowen, as they attempt to make inroads to tackle the most pressing issues facing the sector.[/vc_column_text][/vc_column][/vc_row]

Australia to Order Highest Recorded Number of Flu Vaccines

[vc_row][vc_column][vc_column_text]With many experts stating this is the worst year seen and already equal numbers of recorded diagnoses this year as the entire of 2018.

Minister for Health Greg Hunt reinforced the message that his department will continue to support evidence-based public health initiatives such as vaccination, which he described as ‘the most effective way to protect individuals and the broader community from the flu’.[/vc_column_text][/vc_column][/vc_row]